Abstract
This article outlines the use of high-intensity/high-frequency, high-intensity/low-frequency transcutaneous nerve stimulation in the reduction of muscular headache pain. The existing data on endogenous opiate and nonopiate pain control mechanisms and information from clinical trials are presented to substantiate the use of this treatment modality. The difficulty in running controlled studies for this modality is also explained.
Additional information
Notes on contributors
Gerard L. Lapeer
Gerard L. Lapeer, D.D.S.
Dr. Lapeer graduated from the Faculty of Dentistry at the University of Toronto. Ontario, Canada, in 1977. He is a fellow of the American Association of Hospital Dentists and the Academy of Dentistry International. He is a member of the International Association for the Study of Pain, the American Association for the Study of Headache, the American Academy of Acupuncture Medicine and numerous local, provincial and national professional organizations.
Over the past several years. Dr. Lapeer has focused his professional interest and research on the treatment of chronic and acute craniomandibular pain using endogenous pain control mechanisms.
Dr. Lapeer is Head of the Department of Dentistry at St. Mary's of the Lake Hospital in Kingston, Ontario.